echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Cell Death Dis: Radish seed extract Sulforaphene may be a new treatment for esophageal cancer.

    Cell Death Dis: Radish seed extract Sulforaphene may be a new treatment for esophageal cancer.

    • Last Update: 2020-09-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Esophageal cancer is one of the ten most common cancers in the world, and previous studies have shown that smoking, eating too much hot tea and red meat, poor oral health, and low intake of fresh fruits and vegetables are all associated with esophageal cancer.
    the overall prognosis of the disease is not satisfactory because most patients with esophageal cancer are terminally ill at the time of diagnosis and current treatment strategies are limited.
    it is urgent to develop more effective treatment strategies.
    with cancer-related research, many naturally active substances, such as astratin and resveratrol, have been shown to inhibit a variety of cancers.
    , isothion cyanate in cross-flower vegetables has attracted more and more attention.
    SFE (Sulforaphene, Lysin) isolated from radish seedsstrong anti-cancer activity.
    study found that SFE can inhibit the development of esophageal cancer.
    stethotomy showed that SFE was able to induce apoptosis and that cell cycles were stuck in the G2/M phase.
    , cell migration and transwell chamber experiments have shown that SFE can impair the ability of esotratic cancer cells to migrate.
    chip results showed that the effects of SFE on esophageal cancer cells were associated with SCD (hard lipid coenzyme A desaturation enzyme), CDH3 (calcium mucous protein 3), MAP2K3 (silk rift active protein kinase kinase 3), and GADH45B (growth-stagnating DNA damage induced protein beta).
    SCD and CDH3 can promote the metastasis of esophageal cancer by activating the Wnt signaling pathway, while the last two genes are involved in the positive feedback loop of GED45B-MAP2K3-p38-p53, thereby inhibiting the growth of esophageal cancer.
    previous study found that GED45B was the target gene for p53, in which researchers confirmed that it could raise the phosphorylation levels of MAP2K3 in esophedic cancer cells, which in turn activated p38 and p53.
    SFE can improve the expression level of MAP2K3 and GDD45B and further stimulate the feedback loop to better play the anti-tumor effect.
    , these results show that lysinepotential anti-cancer effect and inhibits metastasis and growth of esophageal cancer.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.